The subsequent identification of mutations in the SLC16A2 gene encoding the monocarboxylate transporter 8 (MCT8)9,15 established AHDS as the first genetically resolved neurodevelopmental disorder due to defective thyroid hormone metabolism. Here, SLC16A2 is linked to Allan-Herndon-Dudley syndrome.